Low-density lipoprotein cholesterol levels and treatment intensity in secondary prevention of patients with ischaemic heart disease in the primary care setting: a real-world data registry study
Increased LDL-C drug treatment improvement, monitoring, and adherence to guideline recommendations are necessary for patients with ischaemic heart disease. Sex and age are potential factors associated with inadequate lipid-lowering treatment intensity and poor LDL-C control that might worsen cardiovascular outcomes in high-risk patients, leading to avoidable inequity among patients who visit the primary health setting.
Authors
- Luis González‐de Paz (ORCID: https://orcid.org/0000-0002-4767-8121)
- Carlos Falces (ORCID: https://orcid.org/0000-0002-3483-3786)
- Antoni Sisó‐Almirall (ORCID: https://orcid.org/0000-0001-9832-2689)
- Núria Sánchez-Ruano (ORCID: https://orcid.org/0000-0003-4461-2503)
- Encarna Sánchez
- Anna Fibla-Matamoros
Institutions
- Cardiovascular Institute Hospital (JP)
- Consorci d’Atenció Primària de Salut Barcelona Esquerra (ES)
- Hospital Clínic de Barcelona (ES)
- Primary HealthCare (MT)
- Institute for Atherosclerosis Research (RU)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Institute of Child and Mother Health (BD)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- BJGP Open
- Published
- 2025-03-12
- DOI
- https://doi.org/10.3399/bjgpo.2024.0220
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00